trending Market Intelligence /marketintelligence/en/news-insights/trending/jLIBSNBjW9Yr06jvLq2REw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Corindus Vascular Robotics Inc. stockholders approved Siemens Healthineers AG's $1.1 billion acquisition of the company.

The Waltham, Mass.-based maker of robotic-assisted systems said stockholders also approved certain compensation to be paid to some of its executives in connection with the merger.

Germany's Siemens Healthineers announced the acquisition in August, agreeing to pay in cash $4.28 apiece for Corindus common stock and $85.60 apiece for series A and series A-1 preferred stocks.

Corindus will be delisted from the NYSE American once the transaction closes Oct. 29.

Citigroup Global Markets Inc. and Cadwalader Wickersham & Taft LLP advised Corindus on the deal.